By Natalie Rahhal Acting Us Health Editor
Published: 16:44 GMT, 3 February 2020 | Updated: 16:44 GMT, 3 February 2020
The cost of HIV medications in the US has surged by 35 percent since 2012, a new study finds.
What's more, the price hikes have exceeded that rise in inflation by 3.5-fold, according to research from Massachusetts General Hospital.
Poverty was identified as a leading risk factor for HIV by the Centers for Disease Control and Prevention in 2010, meaning that people with low incomes are at greater risk for the condition, and less likely to be able to afford drugs to suppress it.
Getting more people treatment for HIV means less risk of transmission and better chances to meet the Trump administration's goal of all but ending HIV in the US by 2030 - but the new study's authors suggest it will require more financial support.
Prices of the most commonly used antiretroviral drugs to treat HIV have increased year after year since 2012, surging by 2018, a new study found
Addressing the cost of insurance and health care - including drugs - was a top priority for former President Barack Obama while he was in office.
Lowering drug prices and fighting Big Pharma companies were chief among President Donald Trump's campaign promises in 2016.
Still, health care and medication pricing remain hot button topics in the debates and platforms of candidates running in the 2020 presidential election.
It's not just for people who have HIV for whom drugs are